Dr. Kavisha Singh, M.D., FACC is a Non-Invasive Cardiologist at the Providence Spokane Heart Institute. She established a dedicated Cardio-Oncology clinic in Spokane to serve local cancer patients requiring specialized cardiovascular care. She is board-certified in Internal Medicine, Cardiovascular Disease, Adult Comprehensive Echocardiography, and Nuclear Cardiology.

Dr. Singh earned her B.A. in Chemistry from Pomona College and her M.D. from the Duke-NUS Graduate Medical School. She completed her Internal Medicine residency at Duke University Hospital followed by a Cardiovascular Medicine fellowship at the University of Texas Southwestern Medical Center.

An active clinical educator and researcher, she is a two-time recipient of the Outstanding Clinical Faculty Teaching Award (2021, 2024) from the Internal Medicine Residency in Spokane. Dr. Singh currently serves as the Site Principal Investigator for the HERMES Trial and Co-Principal Investigator for the EXPAND TAVR II Pivotal Trial. Her research focuses on HDL biomarkers, cardiovascular risk assessment, and clinical ultrasound.